Screener
Bio-Rad Laboratories BIO Treasury stock, value, acquired
Treasury stock, value, acquired at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:TreasuryStockValueAcquiredCostMethod.
The source filing: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:19 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000012208-26-000035
| Line item | Common Stock | Additional Paid-in Capital | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Total Stockholders' Equity |
|---|---|---|---|---|---|---|
| Net income (loss) | — | — | — | (527.1) | — | (527.1) |
| Other comprehensive income (loss), net of tax | — | — | — | — | (46.3) | (46.3) |
| Stock compensation expense | — | 15.0 | — | — | — | 15.0 |
| Purchase of treasury stock | — | — | (47.3) | — | — | (47.3) |
| Reissuance of treasury stock | — | (1.0) | 4.4 | — | — | 3.4 |
| Option premium received for structured purchases of treasury stock | — | 0.5 | — | — | — | 0.5 |
| Excise tax on stock repurchase | — | — | (0.5) | — | — | (0.5) |
| Balance at March 31, 2026 | — | $490.5 | $(1,053.0) | $7,649.2 | $(235.4) | $6,851.3 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Bio-Rad Laboratories's treasury stock, value, acquired?
- Bio-Rad Laboratories (BIO) reported treasury stock, value, acquired of $47.3M in Q1 2026.
- How has Bio-Rad Laboratories's treasury stock, value, acquired changed year-over-year?
- Bio-Rad Laboratories's treasury stock, value, acquired decreased by 53.1% year-over-year, from $100.9M to $47.3M.
Ask your AI about Bio-Rad Laboratories's treasury stock, value, acquired.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude